1.44Open1.44Pre Close0 Volume11.19K Open Interest10.00Strike Price0.00Turnover293.06%IV17.13%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry1.44Extrinsic Value100Contract SizeAmericanOptions Type-0.3886Delta0.0932Gamma7.17Leverage Ratio-0.1211Theta-0.0009Rho-2.79Eff Leverage0.0054Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals(EYPT.US)$
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
📊⚡️📊
No comment yet